Sharechat Logo

Agresearch gets GM cattle trials approved on second attempt

Thursday 15th April 2010

Text too small?

Genetically modified cows, sheep and goats will be bred to seek new human medicines, improve the composition of milk, and allow study of disease resistance at Agresearch's Ruakura research Hamilton, in a critical decision for GM science in New Zealand.

The Environmental Risk Management Authority granted the application today after Agresearch was required to reapply, having failed to convince ERMA of the benefits of the research. 

President of the New Zealand Institute of Agricultural and Horticultural Science, Associate Professor Jon Hickford, said the approval had been expected.

"AgResearch's first attempt to get this approval through was denied as they failed to be specific about the benefit of the GM work they proposed and because they were asking for a broad license to manipulate a wide variety of animals and cells in a variety of ways," he said, in comments supplied by the Science Media Centre. 

"This was interpreted in court last year to be one step too far."

The experimental genetic modification will seek human therapeutic proteins, or with altered levels of endogenous proteins for the study of gene function, milk composition and disease resistance. 

"Full containment" regulations will apply, meaning two-metre high, double fencing of outdoor facilities and measures to prevent animal products from entering the food chain.

ERMA considered "the main benefit of this research to be an increase in scientific knowledge and the capacity for innovation in New Zealand".

 

 

Businesswire.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

PYS - PaySauce FY26 Full Year Result and Annual Report
IFT - Infratil Full Year Results for the year ended 31 March 2026
May 27th Morning Report
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026
PEB - Advancing Medicare Coverage Goals; Cost Contained
TRU - TruScreen Completes Oversubscribed Placement
EROAD Continues Transformation, Reports FY26 Results
May 25th Morning Report